SCINTIMUN Trademark
Trademark Overview
On Friday, March 14, 2025, a trademark application was filed for SCINTIMUN with the United States Patent and Trademark Office. The USPTO has given the SCINTIMUN trademark a serial number of 79429309. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Tuesday, May 26, 2026. This trademark is owned by Telix Pharmaceuticals Limited. The SCINTIMUN trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:
Medical apparatus, namely, infusion and injection devices for administering drugs and diagnostic radiopharmaceuticals; apparatus for medical purposes in the nature of drug delivery devices sold empty, namely, syringes and infusion sets for diagnostic radiopharmaceuticals; medical devices for treating cancer; diagnostic imaging apparatus for medical use being medical imaging apparatus for diagnosing medical conditions
Chemical preparations for pharmaceutical purposes, namely, diagnostic radiopharmaceutical preparations; pharmaceutical preparations for the imaging, diagnosing and monitoring of cancer, namely, contrast media for use with imaging medical equipment, diagnostic reagents and contrast media for medical use, diagnostic radiopharmaceutical preparations, and radiopharmaceutical imaging and detection agents for diagnosing and monitoring cancer; pharmaceutical preparations for the treatment of cancer; radiopharmaceutical imaging and detection agents for diagnosing and monitoring cancer
General Information
| Serial Number | 79429309 |
| Word Mark | SCINTIMUN |
| Filing Date | Friday, March 14, 2025 |
| Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
| Status Date | Tuesday, May 26, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, June 16, 2026 |
Trademark Statements
| Goods and Services | Medical apparatus, namely, infusion and injection devices for administering drugs and diagnostic radiopharmaceuticals; apparatus for medical purposes in the nature of drug delivery devices sold empty, namely, syringes and infusion sets for diagnostic radiopharmaceuticals; medical devices for treating cancer; diagnostic imaging apparatus for medical use being medical imaging apparatus for diagnosing medical conditions |
| Goods and Services | Chemical preparations for pharmaceutical purposes, namely, diagnostic radiopharmaceutical preparations; pharmaceutical preparations for the imaging, diagnosing and monitoring of cancer, namely, contrast media for use with imaging medical equipment, diagnostic reagents and contrast media for medical use, diagnostic radiopharmaceutical preparations, and radiopharmaceutical imaging and detection agents for diagnosing and monitoring cancer; pharmaceutical preparations for the treatment of cancer; radiopharmaceutical imaging and detection agents for diagnosing and monitoring cancer |
| Translation of Words in Mark | The wording "SCINTIMUN" has no meaning in a foreign language. |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, September 13, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, September 13, 2025 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Telix Pharmaceuticals Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | AU |
Trademark Events
| Event Date | Event Description |
| Thursday, August 7, 2025 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Saturday, September 13, 2025 | LIMITATION FROM ORIGINAL APPLICATION ENTERED |
| Monday, September 15, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, September 15, 2025 | APPLICATION FILING RECEIPT MAILED |
| Tuesday, September 16, 2025 | ASSIGNED TO EXAMINER |
| Thursday, September 18, 2025 | NON-FINAL ACTION WRITTEN |
| Friday, September 19, 2025 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Sunday, November 9, 2025 | REFUSAL PROCESSED BY MPU |
| Sunday, November 9, 2025 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Sunday, November 30, 2025 | REFUSAL PROCESSED BY IB |
| Thursday, January 1, 2026 | NEW REPRESENTATIVE AT IB RECEIVED |
| Thursday, January 22, 2026 | NEW REPRESENTATIVE AT IB RECEIVED |
| Thursday, April 30, 2026 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, April 30, 2026 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, April 30, 2026 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, May 19, 2026 | EXAMINERS AMENDMENT -WRITTEN |
| Tuesday, May 19, 2026 | EXAMINERS AMENDMENT E-MAILED |
| Tuesday, May 19, 2026 | EXAMINER'S AMENDMENT ENTERED |
| Tuesday, May 19, 2026 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Tuesday, May 19, 2026 | APPROVED FOR PUB - PRINCIPAL REGISTER |
